Now that Abbott Vascular has pulled out a resounding win at an FDA advisory committee for its Absorb bioresorbable scaffold, it's time to ask what the coverage and reimbursement pictures look like. The coverage part looks easy – perhaps easier than it really is – but it may be more helpful to ask who will be first to give the Absorb a look via the reasonable and necessary lens. CPT + MAC = OMG The easy part of the Absorb situation is the diagnostic-related group discussion because it presumably folds neatly...